July 11, 2013 -- Oregonians with cancer, heart disease, epilepsy and other conditions have been forced to pay an average of 10 times more than necessary for at least 20 blockbuster drugs, according to a report released today by the Oregon State Public Interest Research Group (OSPIRG) and Community Catalyst.
Jul 11, 2013